Insulet Balance Sheet Health
Financial Health criteria checks 6/6
Insulet has a total shareholder equity of $1.5B and total debt of $1.4B, which brings its debt-to-equity ratio to 95.7%. Its total assets and total liabilities are $3.5B and $2.0B respectively. Insulet's EBIT is $393.9M making its interest coverage ratio 45.3. It has cash and short-term investments of $1.1B.
Key information
95.68%
Debt to equity ratio
US$1.40b
Debt
| Interest coverage ratio | 45.3x |
| Cash | US$1.12b |
| Equity | US$1.46b |
| Total liabilities | US$2.01b |
| Total assets | US$3.47b |
Recent financial health updates
Insulet (NASDAQ:PODD) Has A Rock Solid Balance Sheet
Aug 04
Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet?
Apr 07Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly
Dec 18Is Insulet (NASDAQ:PODD) A Risky Investment?
Sep 09Recent updates
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher
Sep 06There May Be Reason For Hope In Insulet's (NASDAQ:PODD) Disappointing Earnings
Aug 14Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold
Aug 14Insulet (NASDAQ:PODD) Has A Rock Solid Balance Sheet
Aug 04Does Insulet (NASDAQ:PODD) Deserve A Spot On Your Watchlist?
Jul 22Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Jun 25What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing?
May 28Subdued Growth No Barrier To Insulet Corporation (NASDAQ:PODD) With Shares Advancing 26%
May 15We Ran A Stock Scan For Earnings Growth And Insulet (NASDAQ:PODD) Passed With Ease
Apr 21Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet?
Apr 07Insulet Leans Bullish (Technical Analysis)
Mar 18Calculating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Mar 05Insulet (NASDAQ:PODD) Is Experiencing Growth In Returns On Capital
Feb 18Earnings Not Telling The Story For Insulet Corporation (NASDAQ:PODD)
Jan 25What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing?
Jan 13Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly
Dec 18Here's Why Insulet (NASDAQ:PODD) Has Caught The Eye Of Investors
Dec 04Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?
Nov 20Returns At Insulet (NASDAQ:PODD) Are On The Way Up
Nov 08Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues
Oct 15Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Oct 03Is Insulet (NASDAQ:PODD) A Risky Investment?
Sep 09Insulet: Turning More Constructive, Valuations Still Stretched
Sep 05
Omnipod 5'S Global Expansion And New Integrations Promise Growth Amid Market And Manufacturing Risks
Expansion into new international markets and integration with leading diabetes sensors position Insulet for increased global penetration and competitive advantage.Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Financial Position Analysis
Short Term Liabilities: PODD's short term assets ($2.3B) exceed its short term liabilities ($1.0B).
Long Term Liabilities: PODD's short term assets ($2.3B) exceed its long term liabilities ($996.2M).
Debt to Equity History and Analysis
Debt Level: PODD's net debt to equity ratio (19%) is considered satisfactory.
Reducing Debt: PODD's debt to equity ratio has reduced from 161.6% to 95.7% over the past 5 years.
Debt Coverage: PODD's debt is well covered by operating cash flow (36.9%).
Interest Coverage: PODD's interest payments on its debt are well covered by EBIT (45.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/05 02:49 |
| End of Day Share Price | 2025/09/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Insulet Corporation is covered by 62 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| null null | Baird |
| Jeffrey Johnson | Baird |